Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SANG KIM

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1023054202
CMS profile
227290
Location
YONKERS, NY

General Payments · PY2018–2024

$7,084.77

  • Reported across 375 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$542.68

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $542.68 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,503.09 133
PY2019 $2,559.91 157
PY2020 $786.40 47
PY2021 $228.15 5
PY2022 $201.27 6
PY2023 $263.27 11
PY2024 $542.68 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $146.95 07/04/2024 Food and Beverage Undisputed 01/23/2026 1124799260 CMS
Abbott Laboratories $24.80 08/08/2024 Food and Beverage Undisputed 01/23/2026 1124799262 CMS
AstraZeneca Pharmaceuticals LP $23.53 03/06/2024 Food and Beverage Undisputed 01/23/2026 1104286324 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $28.59 09/26/2024 Food and Beverage Undisputed 01/23/2026 1117840051 CMS
Boston Scientific Corporation $57.15 02/09/2024 Food and Beverage Undisputed 01/23/2026 1092280000 CMS
Boston Scientific Corporation $22.28 09/12/2024 Food and Beverage Undisputed 01/23/2026 1092279996 CMS
Boston Scientific Corporation $17.99 10/18/2024 Food and Beverage Undisputed 01/23/2026 1092279992 CMS
Boston Scientific Corporation $19.05 11/08/2024 Food and Beverage Undisputed 01/23/2026 1092279994 CMS
Boston Scientific Corporation $23.21 11/15/2024 Food and Beverage Undisputed 01/23/2026 1092279998 CMS
Gilead Sciences, Inc. $15.35 05/10/2024 Food and Beverage Undisputed 01/23/2026 1133769991 CMS
Janssen Pharmaceuticals, Inc $24.96 01/26/2024 Food and Beverage Undisputed 01/23/2026 1078121906 CMS
Janssen Pharmaceuticals, Inc $24.02 05/10/2024 Food and Beverage Undisputed 01/23/2026 1078122032 CMS
Novo Nordisk Inc $20.60 02/15/2024 Food and Beverage Undisputed 01/23/2026 1097631860 CMS
Penumbra, Inc. $46.03 05/23/2024 Food and Beverage Undisputed 01/23/2026 1076201690 CMS
PFIZER INC. $29.14 02/26/2024 Food and Beverage Undisputed 01/23/2026 1131019442 CMS
PFIZER INC. $19.03 12/06/2024 Food and Beverage Undisputed 01/23/2026 1131119744 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.